Adjuvant interferon gamma in patients with drug – resistant pulmonary tuberculosis: a pilot study

BACKGROUND: Tuberculosis (TB) is increasing in the world and drug-resistant (DR) disease beckons new treatments. METHODS: To evaluate the action of interferon (IFN) gamma as immunoadjuvant to chemotherapy on pulmonary DR-TB patients, a pilot, open label clinical trial was carried out in the Cuban re...

Descripción completa

Detalles Bibliográficos
Autores principales: Suárez-Méndez, Roberto, García-García, Idrian, Fernández-Olivera, Norma, Valdés-Quintana, Magalys, Milanés-Virelles, María T, Carbonell, Dalia, Machado-Molina, Delfina, Valenzuela-Silva, Carmen M, López-Saura, Pedro A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC529257/
https://www.ncbi.nlm.nih.gov/pubmed/15500691
http://dx.doi.org/10.1186/1471-2334-4-44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC529257/
https://www.ncbi.nlm.nih.gov/pubmed/15500691
http://dx.doi.org/10.1186/1471-2334-4-44

Ejemplares similares